HLA-DRB1 and malaria: Consequently, strategically replacing one or more selected amino acids at a time in a given non-immunogenic peptide, renders it more immunogenic and a protection inducer against malaria, which can be directly associated with binding to specific HLA-DRβ* alleles, as demonstrated in this experiment.